PL3345900T3 - 2,4-di-(grupa zawierająca azot)-podstawiony związek pirymidynowy i jego sposób otrzymywania oraz zastosowanie - Google Patents
2,4-di-(grupa zawierająca azot)-podstawiony związek pirymidynowy i jego sposób otrzymywania oraz zastosowanieInfo
- Publication number
- PL3345900T3 PL3345900T3 PL16840692.4T PL16840692T PL3345900T3 PL 3345900 T3 PL3345900 T3 PL 3345900T3 PL 16840692 T PL16840692 T PL 16840692T PL 3345900 T3 PL3345900 T3 PL 3345900T3
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- containing group
- nitrogen containing
- pyrimidine compound
- substituted pyrimidine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510552982 | 2015-08-31 | ||
| CN201610471043.7A CN106117185B (zh) | 2015-08-31 | 2016-06-22 | 2,4‑二含氮基团取代嘧啶类化合物及其制备方法和应用 |
| PCT/CN2016/091755 WO2017036263A1 (zh) | 2015-08-31 | 2016-07-26 | 2,4-二含氮基团取代嘧啶类化合物及其制备方法和应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3345900T3 true PL3345900T3 (pl) | 2024-10-28 |
Family
ID=57268890
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16840692.4T PL3345900T3 (pl) | 2015-08-31 | 2016-07-26 | 2,4-di-(grupa zawierająca azot)-podstawiony związek pirymidynowy i jego sposób otrzymywania oraz zastosowanie |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11267802B2 (pl) |
| EP (1) | EP3345900B1 (pl) |
| CN (1) | CN106117185B (pl) |
| AU (1) | AU2016314898B2 (pl) |
| CA (1) | CA2997039C (pl) |
| DK (1) | DK3345900T3 (pl) |
| ES (1) | ES2986889T3 (pl) |
| HR (1) | HRP20241103T1 (pl) |
| PL (1) | PL3345900T3 (pl) |
| SI (1) | SI3345900T1 (pl) |
| WO (1) | WO2017036263A1 (pl) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3205650B1 (en) * | 2014-10-11 | 2021-08-04 | Shanghai Hansoh Biomedical Co., Ltd. | Egfr inhibitor, and preparation and application thereof |
| US10329277B2 (en) | 2015-07-16 | 2019-06-25 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(3-methyl-2-OXO-2,3-dihydro-1h-benzo[d]imidazol-1-yl)pyrimidin-2-yl)amino)phenyl)acrylamide hydrochloride as an inhibitor of epidermal growth factor receptor activity |
| CN106928150B (zh) * | 2015-12-31 | 2020-07-31 | 恩瑞生物医药科技（上海）有限公司 | 丙烯酰胺苯胺衍生物及其药学上的应用 |
| WO2017120429A1 (en) | 2016-01-07 | 2017-07-13 | CS Pharmasciences, Inc. | Selective inhibitors of clinically important mutants of the egfr tyrosine kinase |
| CN106883216B (zh) * | 2017-04-06 | 2020-03-13 | 张家港威胜生物医药有限公司 | 一种奥希替尼的制备方法 |
| CN107266426A (zh) * | 2017-08-15 | 2017-10-20 | 南通因诺威医药科技有限公司 | 2‑氨烃基嘧啶类化合物及其制备方法和用途 |
| CN110790749B (zh) * | 2018-08-03 | 2023-07-14 | 北京普祺医药科技股份有限公司 | 一种含氮杂环化合物、药物组合物以及其用途 |
| CN111747950B (zh) | 2019-03-29 | 2024-01-23 | 深圳福沃药业有限公司 | 用于治疗癌症的嘧啶衍生物 |
| CN112409192A (zh) * | 2020-11-26 | 2021-02-26 | 启东东岳药业有限公司 | 一种4-氟-2-甲氧基苯胺的纯化方法 |
| CN115867539B (zh) * | 2020-12-02 | 2025-07-22 | 上海和誉生物医药科技有限公司 | 2,3-二氢-1H-吡咯并[3,2-b]吡啶衍生物、其制备方法和应用 |
| JP2024527402A (ja) * | 2021-07-13 | 2024-07-24 | エイシア セラピューティクス， インコーポレイテッド | 複素環式化合物およびその用途 |
| CN115701429B (zh) * | 2021-08-02 | 2024-03-12 | 上海和誉生物医药科技有限公司 | 4-(1h-吲哚-1-基)嘧啶-2-氨基衍生物及其制备方法和应用 |
| CN116514723A (zh) * | 2023-03-22 | 2023-08-01 | 上海麦克林生化科技股份有限公司 | 一种5,6-2氯-1-乙基-1h-苯并咪唑-2酮(dcebio)的合成方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009262068C1 (en) * | 2008-06-27 | 2015-07-02 | Celgene Car Llc | Heteroaryl compounds and uses thereof |
| DK3686193T3 (da) * | 2011-07-27 | 2022-05-30 | Astrazeneca Ab | 2-(2,4,5-substitueret anilino)pyrimidinforbindelser |
| CN104761544B (zh) * | 2014-01-03 | 2019-03-15 | 北京轩义医药科技有限公司 | Egfr酪氨酸激酶的临床重要突变体的选择性抑制剂 |
| CN111875585B (zh) * | 2014-06-12 | 2023-06-23 | 上海艾力斯医药科技股份有限公司 | 一类激酶抑制剂 |
| CA2949793C (en) * | 2014-06-19 | 2024-02-27 | Ariad Pharmaceuticals, Inc. | Heteroaryl compounds for kinase inhibition |
| CN113121575A (zh) * | 2014-08-25 | 2021-07-16 | 四川海思科制药有限公司 | 一种(取代的苯基)(取代的嘧啶)胺基衍生物及其制备方法和药物用途 |
| EP3205650B1 (en) * | 2014-10-11 | 2021-08-04 | Shanghai Hansoh Biomedical Co., Ltd. | Egfr inhibitor, and preparation and application thereof |
| CN111170998B (zh) * | 2014-11-05 | 2023-04-11 | 益方生物科技(上海)股份有限公司 | 嘧啶或吡啶类化合物、其制备方法和医药用途 |
| WO2016105525A2 (en) * | 2014-12-23 | 2016-06-30 | Dana-Farber Cancer Institute, Inc. | Novel pyrimidines as egfr inhibitors and methods of treating disorders |
| CN105001208A (zh) * | 2015-08-06 | 2015-10-28 | 南京雷科星生物技术有限公司 | 一种表皮生长因子受体egfr抑制剂及其制备方法与用途 |
| CN106928150B (zh) * | 2015-12-31 | 2020-07-31 | 恩瑞生物医药科技（上海）有限公司 | 丙烯酰胺苯胺衍生物及其药学上的应用 |
| WO2017120429A1 (en) | 2016-01-07 | 2017-07-13 | CS Pharmasciences, Inc. | Selective inhibitors of clinically important mutants of the egfr tyrosine kinase |
-
2016
- 2016-06-22 CN CN201610471043.7A patent/CN106117185B/zh active Active
- 2016-07-26 HR HRP20241103TT patent/HRP20241103T1/hr unknown
- 2016-07-26 ES ES16840692T patent/ES2986889T3/es active Active
- 2016-07-26 DK DK16840692.4T patent/DK3345900T3/da active
- 2016-07-26 CA CA2997039A patent/CA2997039C/en active Active
- 2016-07-26 WO PCT/CN2016/091755 patent/WO2017036263A1/zh not_active Ceased
- 2016-07-26 AU AU2016314898A patent/AU2016314898B2/en active Active
- 2016-07-26 US US15/755,572 patent/US11267802B2/en active Active
- 2016-07-26 PL PL16840692.4T patent/PL3345900T3/pl unknown
- 2016-07-26 EP EP16840692.4A patent/EP3345900B1/en active Active
- 2016-07-26 SI SI201631842T patent/SI3345900T1/sl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017036263A1 (zh) | 2017-03-09 |
| CN106117185B (zh) | 2017-11-07 |
| AU2016314898A1 (en) | 2018-04-26 |
| ES2986889T3 (es) | 2024-11-13 |
| HRP20241103T1 (hr) | 2024-11-08 |
| EP3345900A4 (en) | 2019-04-10 |
| US20200331891A9 (en) | 2020-10-22 |
| US20200165227A1 (en) | 2020-05-28 |
| HK1250706A1 (en) | 2019-01-11 |
| CA2997039C (en) | 2020-09-22 |
| EP3345900A1 (en) | 2018-07-11 |
| CA2997039A1 (en) | 2017-03-09 |
| US11267802B2 (en) | 2022-03-08 |
| DK3345900T3 (da) | 2024-08-19 |
| EP3345900B1 (en) | 2024-06-12 |
| AU2016314898B2 (en) | 2019-06-27 |
| CN106117185A (zh) | 2016-11-16 |
| SI3345900T1 (sl) | 2024-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI3345900T1 (sl) | 2,4-di(dušik-vsebujoča skupina)-substituirana pirimidinska spojina in postopek priprave ter uporaba le-te | |
| SG11202000532SA (en) | Compounds, compositions and methods | |
| PL3676297T3 (pl) | Związki, kompozycje i sposoby | |
| PL3207130T3 (pl) | Kompozycje deaminazy adenozyny 2 (ada2), jej warianty i sposoby ich zastosowania | |
| PT3421038T (pt) | Compostos de naftiridina, combinações médicas e sua utilização | |
| ZA201908488B (en) | Substituted nitrogen containing compounds | |
| IL262020B (en) | Grisiofulvin compound, preparations containing it and its uses | |
| IL270505B1 (en) | Compounds, preparations and methods | |
| SG11202007554TA (en) | Dioxazoline compound, preparation method therefor, and uses thereof | |
| ZA201805600B (en) | Pyrimidine seven-membered-ring compounds, preparation method therefor, pharmaceutical composition thereof, and uses thereof | |
| GB201513614D0 (en) | Compositions, compounds and methods and uses relating thereto | |
| SG11201809760TA (en) | Novel 2,4,6-trisubstituted s-triazine compound, preparation method therefor, and use thereof | |
| PT3350150T (pt) | 1,1-difeniletilenos substituídos por alcenilfenoxilo, processos para a sua preparação e sua utilização | |
| HRP20200104T8 (hr) | Novi heterociklični spoj, metoda za pripremu istog, i farmaceutska kompozicija koja sadrži isto | |
| SG11201705533SA (en) | Levelling compound, its use and manufacture | |
| PL3263133T3 (pl) | Związek pirydynonu i jego zastosowanie | |
| IL256252B (en) | Imidazodiazepine compound, preparations containing it and its uses | |
| IL255042A0 (en) | Amphiphilic compounds, their preparations and uses | |
| IL259900A (en) | Aminoazole derivatives, compositions containing same and uses thereof | |
| SG11202001569SA (en) | Marker compositions with nitrogen compounds, and methods for making and using same | |
| EP3293179A4 (en) | Amide compound and the preparation method and use thereof | |
| ZA201708307B (en) | Improved herbicidal composition, method and use | |
| GB2542135B (en) | A fungicidal composition, method and use of the same | |
| GB201518402D0 (en) | Products, uses & methods (8) | |
| GB201510891D0 (en) | Products, uses & methods (7) |